A consensus document by a group of representatives from primary and secondary care has been published on the management of diabetes for patients at risk or with confirmed COVID-19.

Cumulative incidences of diagnosed and symptomatic VTE are increased in COVID-19 patients hospitalized in a Dutch hospital, with higher risk in those admitted to the ICU as compared to the general ward.

This observational study in 184 patients with COVID-19 pneumonia admitted to the ICU in the Netherlands showed a cumulative incidence of venous thromboembolism and arterial thrombotic complications of 31%.

This presentation is part of a webinar on COVID-19, ACE2 and RAAS inhibition and focuses on the scientific data that is available on the ACE2 receptor and RAAS inhibitors.

As part of a webinar on COVID-19, ACE2 and RAASi, prof. Epstein presents what the clinical implications are of discontinuation of RAASi in COVID-19 patients and strongly recommends to continue use of these medications.

As many questions arise on COVID-19, ACE2 and RAAS inhibition, 3 experts discuss some of the issues on this topic as part of a webinar.

This commentary article describes the function of ACE2, the receptor responsible for SARS-CoV-2 entry, and describes why continued use of RAS blockers during the COVID-19 pandemic is recommended.

In a letter to the editor, Baldi and colleagues describe a study on the incidence of out-of-hospital cardiac arrest in 4 provinces in Lombardy, Italy, during the initial outbreak of COVID-19.

This article discusses obesity from a cardiovascular, cardiorespiratory and inflammatory perspective and describes how obesity could potentially contribute to severe COVID-19 illness.

A guidance document, published by the ESC, provides recommendations on how to diagnose and manage CVD in COVID-19 patients and on other aspects of CV care during the outbreak.

A short survey among EPCCS Council members shows which persons are being tested for possible COVID-19 infection and whether GPs are involved in testing.

An initiative of cardiologists and the Dutch CardioVascular Alliance has resulted in the start of the CAPACITY COVID registry, to collect CV data of COVID-19 patients. The initiators call to join now!